ET
HRMY icon

Entropy Technologies’s Harmony Biosciences HRMY Stock Holding History

Entropy Technologies’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Sell
10,107
-9,766
-49% -$308K 0.01% 747
2026
Q1 		$557K Buy
+19,873
New +$652K 0.03% 563
2024
Q1 		– Sell
-14,350
Closed -$464K – 786
2023
Q4 		$464K Buy
+14,350
New +$401K 0.09% 363

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Entropy Technologies's HRMY Position: Q2 2026 in Review

Entropy Technologies reduced its Harmony Biosciences (HRMY) stake by 49% in Q2 2026, selling an estimated $308K and leaving 10,107 shares worth $368K. The position accounts for 0.01% of the portfolio, ranked #747.

Entropy Technologies first reported a position in HRMY in Q4 2023 and has held it in 3 quarters since. The position peaked at $557K in Q1 2026. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Entropy Technologies held 10,107 shares of Harmony Biosciences worth $368K as of Q2 2026.
  • Entropy Technologies sold 9,766 Harmony Biosciences shares in Q2 2026, an estimated $308K.
  • Harmony Biosciences made up 0.01% of Entropy Technologies's portfolio in Q2 2026, its #747 holding.
  • Entropy Technologies first reported a position in Harmony Biosciences in Q4 2023 and has held it in 3 quarters since.
  • Entropy Technologies's Harmony Biosciences position peaked at $557K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.